A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients

NCT02088060 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
150
Enrollment
OTHER
Sponsor class

Stopped Following the expiry of the original research grant, no follow-up financing could be provided to complete the study.

Conditions

Interventions

Sponsor

Central Institute of Mental Health, Mannheim

Collaborators